A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
To assess the safety (especially skin findings) and pharmacokinetics by applying 0.3%, 1%, or 3% formulation of 5g OPA-15406 ointment to a 1000 cm2 area as a single-dose and as a multiple-dose twice daily for 2 weeks in Japanese healthy adult male subjects.
Epistemonikos ID: 4c57f7c28c77b2a0a1a90d1d665d56cc2938acbd
First added on: May 12, 2024